| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/07/2007 | WO2007064859A2 Compound and method for suppressing retroviral replication |
| 06/07/2007 | WO2007064853A2 Locked nucleic acid oligonucleotides |
| 06/07/2007 | WO2007064724A2 Plants having improved growth characteristics and methods for making the same |
| 06/07/2007 | WO2007064437A2 Methods for production of receptor and ligand isoforms |
| 06/07/2007 | WO2007064163A1 Non-activated wnt inhibition polypeptides and method for preparing the same |
| 06/07/2007 | WO2007063907A1 Sugar chain adduct of peptide and pharmaceutical comprising the same as active ingredient |
| 06/07/2007 | WO2007063664A1 Vascular aging-predicting factor and utilization of the same |
| 06/07/2007 | WO2007063336A1 Reeler domain containing protein |
| 06/07/2007 | WO2007063301A1 Receptor-specific tumour necrosis factor-related apoptosis-inducing ligand (trail) variants |
| 06/07/2007 | WO2007063299A1 Method for the purification of alpha-1-antitrypsin |
| 06/07/2007 | WO2007063133A2 Genes useful for the industrial production of citric acid |
| 06/07/2007 | WO2007063131A1 A generic assay for monitoring endocytosis |
| 06/07/2007 | WO2007063129A2 Insolation of peptides , polypeptides and proteins |
| 06/07/2007 | WO2007063024A2 Keratin-binding effector molecules containing reactive dyes |
| 06/07/2007 | WO2007062852A2 ANTI-Aβ GLOBULOMER ANTIBODIES, ANTIGEN-BINDING MOIETIES THEREOF, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCING SAID ANTIBODIES, COMPOSITIONS COMPRISING SAID ANTIBODIES, USES OF SAID ANTIBODIES AND METHODS OF USING SAID ANTIBODIES |
| 06/07/2007 | WO2007062844A1 Chemokine-mucin fusions linked to glycosylphosphatidylinositol (gpi)-anchors in tissue regeneration and as tumour immune adjuvants |
| 06/07/2007 | WO2007062819A2 Multimeric complexes of antigens and an adjuvant |
| 06/07/2007 | WO2007062594A1 Neuregulin variants and methods of screening and using thereof |
| 06/07/2007 | WO2007041317A3 Immunomodulatory compositions and uses therefor |
| 06/07/2007 | WO2007039458A3 Hiv peptide conjugates and uses thereof |
| 06/07/2007 | WO2007038073A3 Mutations and polymorphisms of hdac11 |
| 06/07/2007 | WO2007036233A3 Dekkera/brettanomyces cytosine deaminases and their use |
| 06/07/2007 | WO2007033383A3 Process for production of bivalirudin |
| 06/07/2007 | WO2007031867A3 A hepatitis c virus non-stru tural ns3/4a fusion gene |
| 06/07/2007 | WO2007031581A3 Plant yield improvement by group 3 lea expression |
| 06/07/2007 | WO2007030748A3 Methods and compositions for diagnosis and immunotherapy of pollen allergy |
| 06/07/2007 | WO2007028633A3 Treatment of diabetes related obesity |
| 06/07/2007 | WO2007025760A3 Melanoma-associated mhc class i associated oligopeptides and the uses thereof |
| 06/07/2007 | WO2007014726A3 Thaumatin from transgenic barley |
| 06/07/2007 | WO2007011415A3 Rhob variants and methods comprising the use thereof |
| 06/07/2007 | WO2007006573A3 Variant iaspp polypeptide and screening assay |
| 06/07/2007 | WO2007005627A3 Tuberculosis antigen detection assays and vaccines |
| 06/07/2007 | WO2007000770A3 Protein kinase c inhibitors for prevention of insulin resistance and type 2 diabetes |
| 06/07/2007 | WO2006131564A3 Novel cysteine-depleted hydrophobin fusion proteins, their production and use thereof |
| 06/07/2007 | WO2006130806A3 Assay for agonists and antagonists of ion channels and for regulators of genetic expression |
| 06/07/2007 | WO2006113277A3 Multivalent soluble tyrokinase receptor that bind angiogenic factor |
| 06/07/2007 | WO2006107924B1 Ehrlichia canis diva (differentiate infected from vaccinated animals) |
| 06/07/2007 | WO2006095086A3 Traceability of cellular cycle anomalies targeting oncology and neurodegeneration |
| 06/07/2007 | WO2006040479A3 Plant promoters and uses thereof |
| 06/07/2007 | WO2006016960A3 Method for purifying a protein of the cystine-knot superfamily |
| 06/07/2007 | WO2005058937A3 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 |
| 06/07/2007 | WO2005052132A3 Mbms as modifiers of branching morphogenesis and methods of use |
| 06/07/2007 | WO2005033293A3 Hypoxia - responsive human cngh-0002 genes and polypeptides |
| 06/07/2007 | WO2004110369A3 Cell surface protein associated with human chronic lymphocytic leukemia |
| 06/07/2007 | WO2004106506A3 Crystallographic structure of trypanosoma cruzi proline racemase (tcpraca) and uses thereof |
| 06/07/2007 | WO2004063214A3 Antibodies that specifically recognize sumo-conjugated proteins |
| 06/07/2007 | WO2002077157A3 Insect nuclear receptor genes and uses thereof |
| 06/07/2007 | US20070130655 and processing of transgenic sugarcane for the recovery of high value proteins; using a nucleic acid encoding the promoter of a sugarcane proline rich protein |
| 06/07/2007 | US20070130633 Rice regulatory sequences for gene expression in defined wheat tissue |
| 06/07/2007 | US20070130630 Cell with improved secretion mediated by mrga protein or homologue |
| 06/07/2007 | US20070130629 Renal Regulatory Elements and Methods of Use Thereof |
| 06/07/2007 | US20070130628 Method for producing immortalised antibodies-secreting cells |
| 06/07/2007 | US20070129324 Mammalian MDM2 binding proteins and uses thereof |
| 06/07/2007 | US20070129322 Recombinant protective protein from Streptococcus pneumoniae |
| 06/07/2007 | US20070129319 Genes encoding human deubiquitinating enzymes |
| 06/07/2007 | US20070129307 Insulin epitopes for the treatment of type 1 diabetes |
| 06/07/2007 | US20070129305 Cell penetrating peptides for intracellular delivery of molecules |
| 06/07/2007 | US20070129303 culture product protein obtained from culturing kidney epithelial cells of BSC-1 African green monkey kidney epithelial cell line; for perfusing ex vivo a donor human kidney, intended for transplantation into a new host; treating and diagnosing patients with kidney disease |
| 06/07/2007 | US20070129302 Il-17c antagonists and methods of using the same |
| 06/07/2007 | US20070129301 Methods and compositions for modulating hgf/met |
| 06/07/2007 | US20070129300 Cytotoxic factors for modulating cell death |
| 06/07/2007 | US20070129298 In-solution activation of factor vii |
| 06/07/2007 | US20070129295 Method for purifying fsh |
| 06/07/2007 | US20070129294 Compound and method of treatment |
| 06/07/2007 | US20070129287 Hemoglobin conjugates |
| 06/07/2007 | US20070129284 Single-chain insulin |
| 06/07/2007 | US20070129281 Pharmaceutical compounds |
| 06/07/2007 | US20070128721 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 06/07/2007 | US20070128717 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences |
| 06/07/2007 | US20070128703 An immobilized acceptor having at least two sugar units is contacted with Pasteurella multocida transferases selected from pmHAS, pmCS, pmHS, PglA, in a reaction medium with a sugar precursor selected from uridine diphosphate (UDP)-glucosamine, UDP-N-acetylglucosamine, or UDP-N-acetylgalactosamine |
| 06/07/2007 | US20070128701 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 06/07/2007 | US20070128700 Methods to culture circovirus |
| 06/07/2007 | US20070128699 Using formation of binding complex between oncogenic human papilloma viral protein E6 and PDZ domain protein as diagnostic indicator of cell proliferative disorders |
| 06/07/2007 | US20070128698 Peptide constructs for treating autoimmune and related diseases |
| 06/07/2007 | US20070128697 gene therapy; neural epidermal growth factor-like 1(NELL); promoting cartilage formation or repair |
| 06/07/2007 | US20070128696 Recombinant DNA, gene expression vectors, and transformants capable of expressing a gene without inducing gene expression with an inducer; genetic engineering |
| 06/07/2007 | US20070128695 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 06/07/2007 | US20070128694 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 06/07/2007 | US20070128692 Chimeric empty capsids of the infectious bursal disease viruse (ibdv), obtainment process and applications |
| 06/07/2007 | US20070128690 gene sequences isolated from Trichoderma reesei; two genes encoding proteins comprising a cellulose binding domain, one encoding an arabinofuranosidase and one encoding an acetylxylanesterase; useful in textile and detergent industry and in pulp and paper industry; for converting biomass to sugars |
| 06/07/2007 | US20070128676 Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene |
| 06/07/2007 | US20070128672 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 06/07/2007 | US20070128667 Secreted neural apoptosis inhibiting proteins |
| 06/07/2007 | US20070128662 Photoreactive regulator of protein function and methods of use thereof |
| 06/07/2007 | US20070128653 Human HAC3 |
| 06/07/2007 | US20070128645 Use of KIAA0172 gene in treatment and diagnosis of diseases as well as in pharmaceutical development |
| 06/07/2007 | US20070128642 Clearing misfolded proteins from blood via incubation with proteon nucleation center (PNC) which comprise metallic nanoparticles consisting of copper, zinc and/or iron; diagnosing metabolic disorders |
| 06/07/2007 | US20070128638 Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus |
| 06/07/2007 | US20070128637 Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus |
| 06/07/2007 | US20070128630 Identifying a T-cell epitope in protein, modifying protein to neutralize T-cell epitope such that the modified protein induces less than or substantially equal the baseline proliferation of naive T-cells, and wherein the allergenicity of protein is reduced |
| 06/07/2007 | US20070128627 A carrier and a steroid receptor coactivator-1 and transcription intermediary factor-2 Associated Modulatory Protein (STAMP) that can modulate transcription of glucocorticoid-, progesterone-, mineralocorticoid- and androgen-responsive genes; conception (contraception), infertility, diabetes, cancer etc |
| 06/07/2007 | US20070128622 hGH-NV cDNA chimera; increases the production of recombinant polypeptides by combining pieces of several different isoforms of a given gene to make a chimeric isoform of the gene or by inserting several copies of the coding region in tandem into a transformation vector |
| 06/07/2007 | US20070128619 Human FGF-21 gene and gene expression products |
| 06/07/2007 | US20070128609 Ddr2 protein with activated kinase activity and preparation method thereof |
| 06/07/2007 | US20070128604 Variants of human taste receptor genes |
| 06/07/2007 | US20070128603 Diagnostic and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 06/07/2007 | US20070128600 Alpha macroglobulin family member |
| 06/07/2007 | US20070128597 Single nucleotide polymorphisms sensitively predicting adverse drug reactions (adr) and drug efficacy |
| 06/07/2007 | US20070128595 Novel polynucleotide and polypeptide sequences and uses thereof |
| 06/07/2007 | US20070128593 Sga-1m, a cancer associated antigen, and uses thereof |